At what point do you consider weaning steroids or immuno-modulating agents in patients with Myasthenia Gravis?

How long do you monitor for clinical stability?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

When would you consider testing for LGI1 antibodies in patients with unexplained neuropathic pain?

When do patients with descending paralysis and suspected botulism require inpatient EMG?

What is your step-wise approach to treating worsening ocular myasthenia gravis symptoms?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.